What is she best known for?
The fields of study she is best known for:
- Gene
- Immune system
- Antibody
Her primary areas of investigation include Receptor, Interleukin 21, Molecular biology, Lymphokine-activated killer cell and Natural killer cell.
Her Receptor research incorporates themes from NK cell activation and Monoclonal antibody.
Interleukin 21 is a primary field of her research addressed under Immunology.
Her biological study focuses on Human leukocyte antigen.
Her research in Lymphokine-activated killer cell focuses on subjects like Cell biology, which are connected to Cell, Co-receptor, Ligand and Cytotoxicity.
Her Natural killer cell research includes themes of Major histocompatibility complex and CD48.
Her most cited work include:
- X-Linked Lymphoproliferative Disease 2b4 Molecules Displaying Inhibitory Rather than Activating Function Are Responsible for the Inability of Natural Killer Cells to Kill Epstein-Barr Virus–Infected Cells (444 citations)
- HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells (395 citations)
- CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: Induction of cytokine release and cytotoxicity against tumors and dendritic cells (389 citations)
What are the main themes of her work throughout her whole career to date?
The scientist’s investigation covers issues in Immunology, Human leukocyte antigen, Receptor, Molecular biology and Interleukin 21.
Her Immunology study incorporates themes from Hematopoietic stem cell transplantation and Transplantation.
Her study in Human leukocyte antigen is interdisciplinary in nature, drawing from both Monoclonal antibody, CD8, Major histocompatibility complex and Virology.
Her studies in Receptor integrate themes in fields like Cell, Natural killer cell, Cytotoxicity and Cell biology.
Her work carried out in the field of Molecular biology brings together such families of science as Cell culture, Transfection, Transmembrane protein, Complementary DNA and Antibody.
Her biological study spans a wide range of topics, including KIR2DL1, Interleukin 12, Lymph node and Innate immune system.
She most often published in these fields:
- Immunology (50.00%)
- Human leukocyte antigen (43.10%)
- Receptor (41.38%)
What were the highlights of her more recent work (between 2013-2021)?
- Immunology (50.00%)
- Human leukocyte antigen (43.10%)
- Hematopoietic stem cell transplantation (16.38%)
In recent papers she was focusing on the following fields of study:
Immunology, Human leukocyte antigen, Hematopoietic stem cell transplantation, Receptor and Transplantation are her primary areas of study.
Her work in Interleukin 21, T cell, NK-92, Human cytomegalovirus and HLA-C are all subfields of Immunology research.
Her research integrates issues of Signal transduction and CD48 in her study of Interleukin 21.
Her work in Human leukocyte antigen covers topics such as Major histocompatibility complex which are related to areas like CD8, T-cell receptor and HLA-E.
Her Hematopoietic stem cell transplantation research includes elements of Leukemia, Acute leukemia and Donor selection.
Michela Falco has researched Receptor in several fields, including Cell, Cell biology, Effector and Immune system.
Between 2013 and 2021, her most popular works were:
- HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders (282 citations)
- Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion (157 citations)
- Human Cytomegalovirus Infection Promotes Rapid Maturation of NK Cells Expressing Activating Killer Ig–like Receptor in Patients Transplanted with NKG2C−/− Umbilical Cord Blood (121 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Immune system
- Antibody
Her main research concerns Immunology, Human leukocyte antigen, Receptor, Hematopoietic stem cell transplantation and Lymphokine-activated killer cell.
Particularly relevant to Innate lymphoid cell is her body of work in Immunology.
Her Receptor research is multidisciplinary, incorporating elements of Cell, Cytotoxic T cell and Immune system.
Her Hematopoietic stem cell transplantation research incorporates elements of Leukemia, Acute leukemia and Incidence.
She's looking at Lymphokine-activated killer cell as part of her Interleukin 12 and Interleukin 21 and Lymphokine-activated killer cell study.
Her Interleukin 12 research focuses on subjects like Natural killer cell, which are linked to Congenital cytomegalovirus infection, Natural killer T cell and B cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
